MINNEAPOLIS, Dec. 15, 2014 /PRNewswire/ -- DaVita
HealthCare Partners Inc. (NYSE: DVA), one of the nation's
largest and most innovative health care communities, today
announced that two of its business units, DaVita Clinical
Research (DCR) and HealthCare Partners Clinical
Research, will merge capabilities to further expand its extensive
clinical research and data analytics services, specifically in
patients with chronic kidney disease (CKD) and end-stage renal
disease (ESRD), as well as primary care and chronic disease
patients treated in an integrated care organization.
The merger allows the two research organizations to offer
comprehensive data analytics capabilities on the longitudinal,
de-identified data of approximately one million active patients
receiving care at DaVita HealthCare Partners centers, including
170,000 U.S. dialysis patients receiving care from DaVita Kidney Care and 836,000 multi-specialty
patients receiving coordinated, integrated care from HealthCare
Partners.
"Since 1997, DaVita Clinical Research has been a leader in
kidney-related trials, epidemiology and data analytics, resulting
in better patient outcomes," said Amy
Young, vice president and general manager of DaVita Clinical
Research. "Our clients appreciate the unique understanding of
patient populations that a health care provider-based CRO like DCR
can deliver."
Biopharmaceutical and medical device developers can gain
insights through access to the analytics capabilities and
understanding of patient data unique to a health care
provider-based clinical research organization.
"HealthCare Partners' extensive patient database is diverse and
reflects real-world evidence in an integrated care organization,"
said Riya Pulicharam, MD, medical director of late phase research
and clinical outcomes at HealthCare Partners Clinical Research. "We
have conducted clinical trials across multiple therapeutic areas
for more than 10 years, and combining our clinical research and
data analytics capabilities with DCR greatly enhances our ability
to meet additional clients' needs."
The combined entity's capabilities – which include claims,
pharmacy and electronic health record data analysis – offer
strategic advantages primed to benefit recipients of its services.
Including the following:
- The combined organization's assets will help boost
research-study enrollment and retention.
- The combined entity offers access to nearly a million primary
care and multi-specialty patients, as well as 280,000 CKD and ESRD
patients, thereby expanding the breadth and depth of the research
being conducted.
- This collaboration combines – and builds on – the intellectual,
financial and human resources necessary to support comprehensive
analysis of scenarios ranging from burden-of-illness studies to
budget impact models to market-sizing assessments.
About DaVita HealthCare Partners
DaVita HealthCare
Partners Inc., a Fortune 500® company, is the parent company of
DaVita Kidney Care and HealthCare
Partners. DaVita Kidney Care is a
leading provider of kidney care in the
United States, delivering dialysis services to patients with
chronic kidney failure and end stage renal disease. As of
September 30, 2014, DaVita Kidney Care operated or provided
administrative services at 2,152 outpatient dialysis centers
located in the United States
serving approximately 170,000 patients. The company also operated
87 outpatient dialysis centers located in 10 countries outside
the United States. HealthCare
Partners manages and operates medical groups and affiliated
physician networks in Arizona,
California, Nevada, New
Mexico, and Florida in its
pursuit to deliver excellent-quality health care in a dignified and
compassionate manner. As of September 30,
2014, HealthCare Partners provided integrated care
management for approximately 836,000 managed care patients. For
more information, please
visit DaVitaHealthCarePartners.com.
About DaVita Clinical Research
DaVita Clinical
Research (DCR), a wholly owned subsidiary of DaVita
HealthCare Partners Inc., uses its extensive, applied database and
real-world healthcare experience to assist pharmaceutical and
medical device companies in the design, recruitment, and completion
of clinical trials including retrospective and prospective
pragmatic trials. DCR's scientific and clinical expertise
spans the lifecycle of product development with more than 175
client companies. DCR's Biorepository, Early Clinical
Research unit (Phase I-IIa) and Late Phase Clinical
Research (Phase IIb through post-marketing) network of
physicians and investigative sites, data research, Health
Economics & Outcomes Research,and Medical
Communications are focused on providing world-class research
in both healthy and chronic disease populations and therapeutic
areas, and especially in CKD and ESRD populations. To learn more
about DCR, visit www.davitaclinicalresearch.com.
DaVita, DaVita Clinical Research, DCR and DaVita HealthCare
Partners are trademarks or registered trademarks of DaVita
Healthcare Partners Inc. All other trademarks are the property of
their respective owners.
Contact Information
Media:
Bianca Violante
(303) 876-6614
bianca.violante@davita.com
Logo -
http://photos.prnewswire.com/prnh/20140318/DC85712LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/davita-clinical-research-and-healthcare-partners-clinical-research-to-merge-and-expand-clinical-trials-and-data-analytics-capabilities-300009473.html
SOURCE DaVita HealthCare Partners